NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

WGRX

Wellgistics Health Inc

Jul 03 • 12:49PM ET

0.9300

Dollar change +0.0170
Percentage change 1.86	%

Healthcare • Pharmaceutical Retailers • USA • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.66	Insider Own	85.76%	Shs Outstand	61.46M	Perf Week	-16.22%
Market Cap	66.83M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	10.23M	Perf Month	-50.27%
Enterprise Value	90.05M	PEG	-	EPS next Q	-	Inst Own	0.49%	Short Float	1.69%	Perf Quarter	-79.61%
Income	-39.20M	P/S	2.31	EPS this Y	-	Inst Trans	231.60%	Short Ratio	0.44	Perf Half Y	-
Sales	28.99M	P/B	12.76	EPS next Y	-	ROA	-132.98%	Short Interest	0.17M	Perf YTD	-75.59%
Book/sh	0.07	P/C	26.52	EPS next 5Y	-	ROE	-5209.10%	52W High	7.04 -86.79%	Perf Year	-
Cash/sh	0.04	P/FCF	-	EPS past 3/5Y	-3533.18% -	ROIC	-331.18%	52W Low	0.87 7.06%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	1.87%	Volatility	17.35% 15.10%	Perf 5Y	-
Dividend TTM	-	EV/Sales	3.11	EPS Y/Y TTM	-1271.04%	Oper. Margin	-129.05%	ATR (14)	0.24	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.15	Sales Y/Y TTM	-	Profit Margin	-135.22%	RSI (14)	30.14	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	0.36	EPS Q/Q	-32881.25%	SMA20	-24.76%	Beta	-	Target Price	-
Payout	-	Debt/Eq	5.75	Sales Q/Q	-	SMA50	-59.83%	Rel Volume	0.36	Prev Close	0.91
Employees	-	LT Debt/Eq	1.64	Earnings	-	SMA200	-67.69%	Avg Volume	391.62K	Price	0.93
IPO	Feb 21, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	74,526	Change	1.86%

Jun-25-25 07:45AM	Wellgistics Health (NASDAQ:WGRX) Accelerates Platform Growth in Q2 With 116 Manufacturer Partnerships, 12,400+ New Products, and 275+ Pharmacies Added to Its Expanding Tech Based Drug Ecosystem (ACCESSWIRE) -8.91%
Jun-10-25 07:45AM	Wellgistics Health Joins OptiSource to Expand Access and Drive Savings for Independent Pharmacies (ACCESSWIRE) -19.32%
May-29-25 07:45AM	Wellgistics Health Announces Preliminary Inclusion in the Russell 2000 and Russell 3000 Indexes (ACCESSWIRE)
May-28-25 07:45AM	Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value (ACCESSWIRE) -7.20%
May-12-25 07:40AM	Wellgistics Health Reports 36% Revenue Growth in Q1 2025 as Manufacturer Access and Pharmacy Onboarding Accelerate (ACCESSWIRE) -5.54%
07:29PM	Loading…
May-09-25 07:29PM	Healthcare firm banks on SEC and Ripple settlement (TheStreet) -9.67%
03:26AM	Florida Pharma Firm Will Use XRP for Real-Time Payments in $50M Financing Deal (CoinDesk)
May-08-25 09:25AM	CORRECTION FROM SOURCE: Wellgistics Health Secures $50M ELOC Facility for XRP Treasury Reserve and Real-Time Payments Infrastructure and Other General Ops (ACCESSWIRE) -30.56%
09:00AM	Wellgistics Health Secures $50M ELOC facility for XRP Treasury Reserve & Real-Time Payments Infrastructure and other general ops (GlobeNewswire)
07:05AM	Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative (ACCESSWIRE)
Apr-30-25 04:25PM	Wellgistics Health Reports Strong Q1 Operational Growth Across Manufacturer, Product, and Pharmacy Expansion with Over 350 New Pharmacies Added to Its Nationwide Network (ACCESSWIRE) +7.96%
Apr-24-25 07:40AM	Wellgistics Names Mark DiSiena as New CFO (ACCESSWIRE)
Apr-15-25 07:40AM	CEO of Wellgistics Health Converts $1.5 Million of Debt to Equity at IPO Price (ACCESSWIRE)
Apr-10-25 07:40AM	Wellgistics Health, Inc. Announces Agreement to Acquire Peek Healthcare Technologies, Inc., to Support Over 2,500 Patients and $1.5MM Annual Revenue (ACCESSWIRE) -9.07%
Mar-27-25 08:05AM	Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025 (GlobeNewswire)
07:40AM	Loading…
Mar-18-25 07:40AM	Wellgistics Health Achieves SOC 2 Type 1 Compliance, Strengthening Security for AI-Driven Pharmacy Solutions and Employer-Based Healthcare Models (GlobeNewswire) +14.61%
Mar-04-25 05:18PM	Wellgistics Health, Inc. Announces Leadership Transition: Brian Norton Appointed as CEO Following Tim Canning's Departure (GlobeNewswire)
07:40AM	Protega Pharmaceuticals collaborates with Wellgistics to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND (GlobeNewswire)
Feb-26-25 07:40AM	Wellgistics Expands Healthcare Ecosystem with Tollo Health Agreement, Targeting Multi-Billion Dollar GLP-1 and Long COVID Market (GlobeNewswire)
Feb-25-25 01:15PM	D. Boral Capital Served as Joint Bookrunner to Wellgistics Health, Inc. (Nasdaq: WGRX) in connection with its $4.0 Million Initial Public Offering (ACCESS Newswire) -9.90%
Feb-24-25 04:05PM	Wellgistics Health, Inc. Announces Closing of $4.0 Million Initial Public Offering (GlobeNewswire) -20.47%
Feb-21-25 08:05AM	Wellgistics Health, Inc. Announces Pricing of $4.0 Million Initial Public Offering (GlobeNewswire)

Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

WGRX

Wellgistics Health Inc

Upgrade your FINVIZ experience